Viewing Study NCT05756920


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT05756920
Status: COMPLETED
Last Update Posted: 2025-07-23
First Post: 2023-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
Sponsor: ABL Bio, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module